Gossamer Bio GOSS
NASDAQ GOSS
$0.14 -0.02 (-11.02%)
As of: Sep 10, 2026 · 11:42 AM EDT

Gossamer Bio (GOSS) Non-Current Debt (2019 - 2023)

Gossamer Bio (GOSS) posted Non-Current Debt of $814000.0 for Q4 2023, down 77.6% on a QoQ basis from $3.6 million in Q3 2023, and down 93.21% year-over-year from $12.0 million in Q4 2022.

Analysis

Gossamer Bio (GOSS) Non-Current Debt (2019 - 2023) Analysis & Trends

Gossamer Bio has reported Non-Current Debt for 5 years, with the latest figure at $814000.0 in Q4 2023.

  • On a quarterly basis, Non-Current Debt fell 93.21% year-over-year to $814000.0 in Q4 2023; TTM through Dec 2023 was $814000.0, a 93.21% decrease from a year earlier, with the FY2023 full-year figure at $814000.0, down 93.21% from the prior year.
  • Non-Current Debt was $814000.0 for Q4 2023 at Gossamer Bio, down from $3.6 million in the prior quarter.
  • The five-year high for Non-Current Debt was $29.2 million in Q1 2022, with the low at $814000.0 in Q4 2023.
  • Average Non-Current Debt over 5 years is $21.5 million, with a median of $28.5 million recorded in 2019.
  • The sharpest annual moves came in 2020 and 2023: Non-Current Debt rose 1.26% in 2020, then sank 93.21% in 2023.
  • Over 5 years, Non-Current Debt stood at $28.5 million in 2019, then advanced by 1.0% to $28.7 million in 2020, then rose by 1.17% to $29.1 million in 2021, then plunged by 58.77% to $12.0 million in 2022, then tumbled by 93.21% to $814000.0 in 2023.
  • The last three Non-Current Debt figures came in at $814000.0 (Q4 2023), $3.6 million (Q3 2023), and $6.4 million (Q2 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 641.22 Bn 620.47 Bn 17.26 Bn 37.34 Bn
2 AbbVie 446.28 Bn 439.71 Bn 12.70 Bn 62.48 Bn
3 Merck 357.56 Bn 350.42 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 268.11 Bn 260.42 Bn 11.24 Bn -
5 Pfizer 156.86 Bn 145.17 Bn 10.94 Bn 60.50 Bn
6 Sanofi 52.10 Bn 44.72 Bn 10.79 Bn 17.02 Bn
7 Revolution Medicines 43.01 Bn 43.01 Bn - -
8 Incyte 24.82 Bn 20.28 Bn 1.57 Bn -
9 United Therapeutics 21.39 Bn 18.73 Bn 683.80 Mn -
10 Gossamer Bio 45.60 Mn -11.42 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 814,000.00
Sep 30, 2023 3.63 Mn
Jun 30, 2023 6.44 Mn
Mar 31, 2023 9.22 Mn
Dec 31, 2022 11.99 Mn
Sep 30, 2022 14.83 Mn
Jun 30, 2022 17.65 Mn
Mar 31, 2022 29.17 Mn
Dec 31, 2021 29.08 Mn
Sep 30, 2021 28.99 Mn
Jun 30, 2021 28.91 Mn
Mar 31, 2021 28.82 Mn
Dec 31, 2020 28.74 Mn
Sep 30, 2020 28.67 Mn
Jun 30, 2020 28.64 Mn
Mar 31, 2020 28.55 Mn
Dec 31, 2019 28.46 Mn
Sep 30, 2019 28.37 Mn
Jun 30, 2019 28.28 Mn